Bruton's tyrosine kinase inhibition for the treatment of allergic disorders. [PDF]
Lin EV, Suresh RV, Dispenza MC.
europepmc +1 more source
Fenebrutinib, a Bruton's tyrosine kinase inhibitor, blocks distinct human microglial signaling pathways. [PDF]
Langlois J +12 more
europepmc +1 more source
Bruton's Tyrosine Kinase Inhibitors with Distinct Binding Modes Reveal Differential Functional Impact on B-Cell Receptor Signaling. [PDF]
Li W +14 more
europepmc +1 more source
Expanded CD16<sup>+</sup>CD56<sup>+</sup>Granzyme B<sup>+</sup> NK like CD8<sup>+</sup> T cells an off target effect of bruton's tyrosine kinase inhibitors in Waldenström macroglobulinemia. [PDF]
Hastak P +16 more
europepmc +1 more source
Arrhythmogenic Ventricular Remodeling by Next-Generation Bruton's Tyrosine Kinase Inhibitor Acalabrutinib. [PDF]
Zhao Y +9 more
europepmc +1 more source
Related searches:
Bruton’s Tyrosine Kinase in Ankylosing Spondylitis
Spine, 2023Study Design. Prospective case-control study. Objective. To explore the role of Bruton’s tyrosine kinase (BTK) in ankylosing spondylitis (AS). Summary of Background Data.
Hsien-Tzung, Liao, Chun-Hsiung, Chen
openaire +2 more sources
Signalling of Bruton's Tyrosine Kinase, Btk
Scandinavian Journal of Immunology, 1999Bruton's tyrosine kinase, which is encoded by the BTK gene, is a cytoplasmic protein tyrosine kinase (PTK) crucial for B‐cell development and differentiation. It belongs to the Tec family of PTKs containing several domains that are characteristic of signalling molecules.
A J, Mohamed +3 more
openaire +2 more sources
Bruton Tyrosine Kinase Degraders
American Journal of Clinical OncologyBruton tyrosine kinase (BTK) is a key enzyme involved in B-cell development and signaling, making it a crucial target in the treatment of B-cell malignancies, such as chronic lymphocytic leukemia and non-Hodgkin lymphoma. While BTK inhibitors (BTKi), such as ibrutinib, have been effective, resistance—both intrinsic and acquired—poses a significant ...
Giorgi, Sabakhtarishvili +3 more
openaire +2 more sources

